Production of plasma proteins for therapeutic use (Record no. 88662)

MARC details
000 -LEADER
fixed length control field 01743nam a2200397 a 4500
001 - CONTROL NUMBER
control field EBC1098891
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240120134258.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120522s2013 njua sb 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2012020857
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780470924310 (cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118356784 (electronic bk.)
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC1098891
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL1098891
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10639275
035 ## - SYSTEM CONTROL NUMBER
System control number (CaONFJC)MIL420582
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)794306445
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QP99.3.P7
Item number P76 2013
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.3/9
Edition number 23
245 00 - TITLE STATEMENT
Title Production of plasma proteins for therapeutic use
Medium [electronic resource] /
Statement of responsibility, etc. edited by Joseph Bertolini, Neil Goss, John Curling.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Hoboken, N.J. :
Name of publisher, distributor, etc. John Wiley & Sons,
Date of publication, distribution, etc. c2013.
300 ## - PHYSICAL DESCRIPTION
Extent xii, 496 p. :
Other physical details ill.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note section 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood proteins
General subdivision Therapeutic use.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bertolini, Joseph.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goss, Neil.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Curling, J. M.
Fuller form of name (John M.)
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ProQuest (Firm)
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=1098891">https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=1098891</a>
Public note Click to View

No items available.